These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia in Japan. Shoji T; Hirai Y; Osawa M; Totsuka K J Infect Chemother; 2014 Mar; 20(3):175-80. PubMed ID: 24462449 [TBL] [Abstract][Full Text] [Related]
69. Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Kim SH; Kang CI; Kim HB; Youn SS; Oh MD; Kim EC; Park SY; Kim BK; Choe KW Infect Control Hosp Epidemiol; 2003 Dec; 24(12):897-904. PubMed ID: 14700404 [TBL] [Abstract][Full Text] [Related]
70. Quality Improvement of Staphylococcus aureus Bacteremia Management and Predictors of Relapse-free Survival. Townsend J; Pelletier J; Peterson G; Matulevicius S; Sreeramoju P Am J Med; 2016 Feb; 129(2):195-203. PubMed ID: 26519616 [TBL] [Abstract][Full Text] [Related]
71. Eradication of a chronic wound and driveline infection after redo-LVAD implantation. Walter V; Stock UA; Soriano-Romero M; Schnitzbauer A; Moritz A; Beiras-Fernandez A J Cardiothorac Surg; 2014 Mar; 9():63. PubMed ID: 24685284 [TBL] [Abstract][Full Text] [Related]
73. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Kreisel K; Boyd K; Langenberg P; Roghmann MC Diagn Microbiol Infect Dis; 2006 Jul; 55(3):179-84. PubMed ID: 16631340 [TBL] [Abstract][Full Text] [Related]
74. Effectiveness of oral cephalexin in antibiotic-course completion for methicillin-susceptible Staphylococcus aureus-induced bacteremic vertebral osteomyelitis. Okumura N; Hayakawa K; Yamamoto K; Yamada G; Mezaki K; Ohmagari N BMC Infect Dis; 2023 May; 23(1):307. PubMed ID: 37158826 [TBL] [Abstract][Full Text] [Related]
75. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222 [TBL] [Abstract][Full Text] [Related]
77. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia. Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230 [TBL] [Abstract][Full Text] [Related]
78. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged. Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374 [No Abstract] [Full Text] [Related]
79. Small colony variants of Staphylococcus aureus and pacemaker-related infection. Seifert H; Wisplinghoff H; Schnabel P; von Eiff C Emerg Infect Dis; 2003 Oct; 9(10):1316-8. PubMed ID: 14609471 [TBL] [Abstract][Full Text] [Related]
80. Effectiveness of early switching from intravenous to oral antibiotic therapy in Staphylococcus aureus prosthetic bone and joint or orthopedic metalware-associated infections. Boclé H; Lavigne JP; Cellier N; Crouzet J; Kouyoumdjian P; Sotto A; Loubet P BMC Musculoskelet Disord; 2021 Mar; 22(1):315. PubMed ID: 33784991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]